Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity

Natural killer-dendritic cell cross-talk in cancer immunotherapy

Administration of dendritic cells in cancer nodules in hepatocellular carcinoma

[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]

The immunotherapy of prostate and bladder cancer

Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial